Glucocorticoids remain the mainstay of treatment of giant cell arteritis. The aim of this review is to establish the optimal schedule of glucocorticoid administration, and to ascertain which other treatments may be used as glucocorticoid-sparing agents.

Improving therapeutic options for patients with giant cell arteritis / Pipitone, Nicolò; Salvarani, Carlo. - In: CURRENT OPINION IN RHEUMATOLOGY. - ISSN 1040-8711. - 20:(2008), pp. 17-22. [10.1097/BOR.0b013e3282f31769]

Improving therapeutic options for patients with giant cell arteritis

SALVARANI, CARLO
2008-01-01

Abstract

Glucocorticoids remain the mainstay of treatment of giant cell arteritis. The aim of this review is to establish the optimal schedule of glucocorticoid administration, and to ascertain which other treatments may be used as glucocorticoid-sparing agents.
20
17
22
Improving therapeutic options for patients with giant cell arteritis / Pipitone, Nicolò; Salvarani, Carlo. - In: CURRENT OPINION IN RHEUMATOLOGY. - ISSN 1040-8711. - 20:(2008), pp. 17-22. [10.1097/BOR.0b013e3282f31769]
Pipitone, Nicolò; Salvarani, Carlo
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1082505
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 22
social impact